Interactive Biosoftware Adds High-Throughput Variant Annotation Software to Portfolio | GenomeWeb

By Uduak Grace Thomas

Interactive Biosoftware has released a new version of its flagship Alamut mutation analysis software designed to identify variants in next-generation sequence data.

Prior to its launch last week, the tool, dubbed Alamut High-Throughput, was tested by clinical laboratories in the US and Europe, including the Partners Healthcare Center for Personalized Genetic Medicine; the Dutch Academic Medical Center; and the Institute of Genetics and Molecular and Cellular Biology in Strasbourg, France.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.